As of March 23, 2026, Heron Therapeutics's top three insider holders are Capital Management Lp Rubric (TenPercentOwner, 30.05Mn shares), Adam Morgan (Director, 8.75Mn shares), Craig A Collard (Chief Executive Officer, 571.71K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Capital Management Lp Rubric | 0 | 30,046,828 | 17 Oct, 2025 | |
| Adam Morgan | 0 | 8,753,290 | 12 Aug, 2025 | |
| Craig A Collard | Chief Executive Officer | 571,710 | 0 | 03 Feb, 2026 |
| Ira Duarte | Evp, Chief Financial Officer | 195,356 | 0 | 03 Feb, 2026 |
| William P Forbes | Evp, Chief Development Officer | 181,773 | 0 | 03 Feb, 2026 |
| Barry D Quart | Chief Executive Officer | 177,989 | 0 | 17 Jan, 2023 |
| Adam Morgan | 123,737 | 0 | 03 Feb, 2026 | |
| Susan Rodriguez | 87,180 | 0 | 04 Feb, 2025 | |
| Lisa Peraza | Vp, Chief Accounting Officer | 55,907 | 0 | 16 Jan, 2024 |
| Craig A Johnson | 53,960 | 0 | 03 Feb, 2026 | |
| Michael Kaseta | 53,960 | 0 | 03 Feb, 2026 | |
| Thomas Cusack | 53,960 | 0 | 03 Feb, 2026 | |
| Sharmila Dissanaike | 53,960 | 0 | 03 Feb, 2026 | |
| Waage Christian | 53,960 | 0 | 03 Feb, 2026 | |
| Waage Christian | 53,960 | 0 | 03 Feb, 2026 | |
| Stephen Davis | 52,032 | 0 | 20 Dec, 2022 | |
| John Poyhonen | President Cco | 46,648 | 0 | 17 Apr, 2023 |
| David Leslie Szekeres | Evp, Chief Operating Officer | 33,754 | 0 | 17 Jul, 2023 |
| Kimberly Manhard | Evp, Drug Development | 28,330 | 0 | 17 Apr, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 30 Jan, 2026 | Sharmila Dissanaike | Common Stock | A | 53,960 | $0.00 | 53,960 | D | A |
| 30 Jan, 2026 | Craig A Johnson | Common Stock | A | 53,960 | $0.00 | 53,960 | D | A |
| 30 Jan, 2026 | Mark Earl Hensley | Restricted Stock Units | A | 188,315 | $0.00 | 188,315 | D | A |
| 31 Jan, 2026 | William P Forbes | Common Stock | A | 11,695 | - | 181,773 | D | M |
| 30 Jan, 2026 | Thomas Cusack | Common Stock | A | 53,960 | $0.00 | 53,960 | D | A |
| 30 Jan, 2026 | Craig A Collard | Restricted Stock Units | A | 800,337 | $0.00 | 800,337 | D | A |
| 30 Jan, 2026 | Waage Christian | Common Stock | A | 53,960 | $0.00 | 53,960 | D | A |
| 30 Jan, 2026 | Waage Christian | Common Stock | A | 53,960 | $0.00 | 53,960 | D | A |
| 30 Jan, 2026 | Ira Duarte | Restricted Stock Units | A | 216,562 | $0.00 | 216,562 | D | A |
| 31 Jan, 2026 | Craig A Collard | Common Stock | A | 34,789 | - | 571,710 | D | M |
| 30 Jan, 2026 | Michael Kaseta | Common Stock | A | 53,960 | $0.00 | 53,960 | D | A |
| 31 Jan, 2026 | Ira Duarte | Common Stock | A | 11,695 | - | 195,356 | D | M |
| 30 Jan, 2026 | Adam Morgan | Common Stock | A | 53,960 | $0.00 | 123,737 | D | A |
| 30 Jan, 2026 | William P Forbes | Restricted Stock Units | A | 188,315 | $0.00 | 188,315 | D | A |
| 30 Jan, 2026 | Mark Earl Hensley | Performance Stock Units | A | 188,314 | $0.00 | 188,314 | D | A |
| 31 Jan, 2026 | Craig A Collard | Restricted Stock Units | D | 34,789 | $0.00 | 417,464 | D | M |
| 31 Jan, 2026 | William P Forbes | Restricted Stock Units | D | 11,695 | $0.00 | 140,332 | D | M |
| 30 Jan, 2026 | William P Forbes | Performance Stock Units | A | 188,314 | $0.00 | 188,314 | D | A |
| 30 Jan, 2026 | Craig A Collard | Performance Stock Units | A | 800,336 | $0.00 | 800,336 | D | A |
| 30 Jan, 2026 | Ira Duarte | Performance Stock Units | A | 216,561 | $0.00 | 216,561 | D | A |